<DOC>
	<DOC>NCT02753309</DOC>
	<brief_summary>This study is looking at the effects of Sirolimus (Rapamycin) on BCG-specific immunity during treatment of non-muscle invasive bladder cancer (NMIBC) with maintenance BCG.</brief_summary>
	<brief_title>A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer</brief_title>
	<detailed_description>This study will evaluate change from baseline in gamma-delta T cell numbers and function and Ag85 peptide-specific T cell responses following treatment.</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>Pathologically (histologically) proven diagnosis of nonmuscle invasive (Ta, Tis or T1) bladder cancer In their treating physician's opinion is a good candidate for BCG therapy Be able to give informed consent Be age 18 or older Not be in an immunosuppressed state (e.g. HIV, use of chronic steroids) Not have active, uncontrolled infections Not be on agents known to alter rapamycin metabolism significantly Not have a reported history of liver disease (e.g. cirrhosis) Not have a prior history of nonbladder cancer unless the cancer is clinically stable and not requiring active treatment except basal cell carcinoma or squamous cell carcinoma of the skin. Not pregnant, or taking effective contraception before rapamycin therapy, during therapy and for 12 weeks after discontinuation of therapy. Have muscleinvasive (â‰¥T2) bladder cancer Unable to give informed consent Age &lt; 18 Immunosuppressed state (e.g. HIV, use of chronic steroids) Active, uncontrolled infections On agents known to alter rapamycin metabolism significantly Another cancer requiring active treatment (except basal cell carcinoma or squamous cell carcinoma of the skin) Patients at risk of pregnancy who are unwilling or unable to take effective contraception before rapamycin therapy, during therapy, and for 12 weeks after discontinuation of therapy. Individuals with a reported history of liver disease (e.g. cirrhosis) Individuals who are not a good candidate for BCG in their treating physician's opinion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>BCG</keyword>
	<keyword>Rapamycin</keyword>
</DOC>